Manufacturing of Active Pharmaceutical Ingredients, Bulk Intermediates, and Nutraceuticals from agricultural byproducts in India.
Annual revenue $5.7M Latest available
Total funding - Funding intelligence
Employees 89 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Andhra Medi Pharma

Andhra Medi Pharma is a company. The company has 89 employees as of March 31, 2024. Andhra Medi Pharma offers products and services including Chitin and Glucosamine.

  • Employees 89 as on 31 Mar, 2024
  • Sectors
    Agriculture
    Healthcare
  • Phone
    Locked
  • Legal Name Andhra Medi Pharma India Pvt. Ltd
  • Jurisdiction Vijayawada, Andhra Pradesh, India
Operational Areas
Agriculture → Aquaculture & Fisheries Unlock Sub-Sector Unlock Segment
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $5.71 M (USD)
    -33.17
    as on Mar 31, 2023
  • Net Profit
    $86.93 K (USD)
    -48.43
    as on Mar 31, 2023
  • EBITDA
    $800.14 K (USD)
    -44.94
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    89

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Andhra Medi Pharma

Andhra Medi Pharma offers a comprehensive portfolio of products and services, including Chitin and Glucosamine.

Product name locked
Category locked
Primary

Chitin is derived from shrimp shells and is utilized as a base material for Glucosamine-based products in various industries.

Product name locked
Category locked
Locked

Glucosamine and its salts are manufactured for applications in medicine, cosmetics, and agriculture from processed shrimp shells.

Funding Insights of Andhra Medi Pharma

Premium access

Detailed funding history for Andhra Medi Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Andhra Medi Pharma

Investments
Premium access

Investment portfolio details for Andhra Medi Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Andhra Medi Pharma

Premium access

Detailed financials for Andhra Medi Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Andhra Medi Pharma Comparisons

Andhra Medi Pharma Primary company
Description
Manufacturing of Active Pharmaceutical Ingredients, Bulk Int...
Location
-
Founded Year
-
Annual Revenue
$5.71 M (USD)
Net Profit
$86.93 K (USD)
EBITDA
$800.14 K (USD)
Employees
89
As of 2024
Premium access

Peer comparison for Andhra Medi Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Andhra Medi Pharma

Premium access

Detailed competitors of Andhra Medi Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Andhra Medi Pharma

Premium access

Complete news archive for Andhra Medi Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Andhra Medi Pharma

As of Mar 31, 2024, the latest employee count at Andhra Medi Pharma is 89.

Annual revenue of Andhra Medi Pharma is $5.71M as on Mar 31, 2023.

Andhra Medi Pharma is recognized as a manufacturer that specializes in the production of Chitin, Chitosan, and Glucosamine from shrimp shells, which are supplied for use in agriculture, medicine, and cosmetics. The company has been established for over a decade, serving global markets across five continents and holding certifications like ISO 22000:2005 and HACCP. With a monthly production capacity exceeding 200 metric tonnes, products are exported to the E.U. and other regions, supported by facilities in India and a marketing office in Spain. Quality standards are maintained through various accreditations, ensuring compliance in international shipments.

Andhra Medi Pharma offers Chitin and Glucosamine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available